4th International Conference on Biochemical Markers for Brain Damage

第四届脑损伤生化标志物国际会议

• 批准号: 7000775
• 负责人: PAULA M BOKESCH
• 金额: $ 2.5万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2006-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7000775
• 关键词: biomarker; brain disorder diagnosis; brain injury; meeting /conference /symposium; spinal cord injury; travel

DESCRIPTION (provided by applicant): This application requests funding support for the 4th International Conference on Biochemical Markers for Brain Damage which will be held in Boothbay Harbor Maine, September 8 -10, 2005. Biochemical Markers for Brain Damage (www.BMBD.lu.se) is an international group of physicians and scientists interested in diagnosing and monitoring brain injury using blood and body fluid assays. Every 2-3 years we meet to present, discuss, and argue the latest technology and innovations in biochemical markers and their use in brain injury diagnosis, monitoring and neuroprotection. Our group covers a broad range of medical specialties from pediatric sports medicine to geriatric stroke rehabilitation. The meeting will feature world renowned speakers with a target audience of biochemists, neurologists, neurosurgeons, cardiac surgeons, anesthesiologists, sports medicine and emergency physicians. Speakers have been specifically selected to bring new insights into the field. The program for BMBD-2005 includes 25 invited lectures and 40 presentations selected from submitted abstracts. Other abstracts will be on display as posters throughout the symposium. The session topics include the use of biochemical markers for acute traumatic/sports brain injury, stroke, perioperative brain injury, dementia and demyelinating diseases. There will also be a session on biomarker development and validity that is designed to enhance communication between academia and industry. Women, minorities and persons with disabilities will receive a discounted registration fee and can attend a seminar to encourage careers in biomarker research. This meeting has been approved for 15 continuing medical education credits by Emory University School of Medicine. The program will be presented live on the Internet and archived for at least a year on the Emory University CME Website where it can be viewed at any time by anyone with Internet access. The program will also be published in the Journal of Neurotrauma. We expect 150-200 registrants.

描述（由申请人提供）：本申请要求为将于2005年9月8日至10日在缅因州的布斯贝港举行的第四届脑损伤生化标志物国际会议提供资金支持。 脑损伤的生化标记物（www.BMBD.lu.se）是一个国际性的医生和科学家组织，他们对使用血液和体液检测诊断和监测脑损伤感兴趣。 每隔2-3年，我们会举行会议，介绍，讨论和辩论生化标志物的最新技术和创新及其在脑损伤诊断，监测和神经保护中的应用。 我们的团队涵盖了从儿科运动医学到老年中风康复的广泛医学专业。 会议将邀请世界知名的演讲者，目标受众包括生物化学家、神经学家、神经外科医生、心脏外科医生、麻醉师、运动医学和急诊医生。 演讲者是专门挑选的，为该领域带来新的见解。 BMBD-2005的计划包括25个特邀讲座和40个从提交的摘要中选出的演讲。 其他摘要将在整个专题讨论会期间作为海报展出。 会议主题包括急性创伤性/运动性脑损伤，中风，围手术期脑损伤，痴呆和脱髓鞘疾病的生化标志物的使用。 还将举行一次关于生物标志物开发和有效性的会议，旨在加强学术界和工业界之间的沟通。 妇女、少数民族和残疾人将获得折扣注册费，并可以参加一个研讨会，以鼓励生物标志物研究的职业。 本次会议已获埃默里大学医学院批准15个继续医学教育学分。 该计划将在互联网上直播，并在埃默里大学CME网站上存档至少一年，任何人都可以随时访问互联网。 该计划也将发表在神经创伤杂志上。 预计将有150-200名注册者。